These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 15586225
1. Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy number. Sato S, Noguchi Y, Wada H, Fujita S, Nakamura S, Tanaka R, Nakada T, Hasegawa K, Nakagawa K, Koizumi F, Ono T, Nouso K, Jungbluth A, Chen YT, Old LJ, Shiratori Y, Nakayama E. Int J Oncol; 2005 Jan; 26(1):57-63. PubMed ID: 15586225 [Abstract] [Full Text] [Related]
3. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer. Odunsi K, Jungbluth AA, Stockert E, Qian F, Gnjatic S, Tammela J, Intengan M, Beck A, Keitz B, Santiago D, Williamson B, Scanlan MJ, Ritter G, Chen YT, Driscoll D, Sood A, Lele S, Old LJ. Cancer Res; 2003 Sep 15; 63(18):6076-83. PubMed ID: 14522938 [Abstract] [Full Text] [Related]
4. NY-ESO-1 expression and immunogenicity in esophageal cancer. Fujita S, Wada H, Jungbluth AA, Sato S, Nakata T, Noguchi Y, Doki Y, Yasui M, Sugita Y, Yasuda T, Yano M, Ono T, Chen YT, Higashiyama M, Gnjatic S, Old LJ, Nakayama E, Monden M. Clin Cancer Res; 2004 Oct 01; 10(19):6551-8. PubMed ID: 15475443 [Abstract] [Full Text] [Related]
5. Comparisons for detecting NY-ESO-1 mRNA expression levels in hepatocellular carcinoma tissues. Wang XY, Chen HS, Luo S, Zhang HH, Fei R, Cai J. Oncol Rep; 2009 Mar 01; 21(3):713-9. PubMed ID: 19212631 [Abstract] [Full Text] [Related]
6. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue. Li M, Yuan YH, Han Y, Liu YX, Yan L, Wang Y, Gu J. Clin Cancer Res; 2005 Mar 01; 11(5):1809-14. PubMed ID: 15756003 [Abstract] [Full Text] [Related]
7. Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer. Sharma P, Gnjatic S, Jungbluth AA, Williamson B, Herr H, Stockert E, Dalbagni G, Donat SM, Reuter VE, Santiago D, Chen YT, Bajorin DF, Old LJ. Cancer Immun; 2003 Dec 18; 3():19. PubMed ID: 14680360 [Abstract] [Full Text] [Related]
8. [Expression of NY-ESO-1/LAGE-1 genes in hepatocellular carcinoma and autologous humoral responses induced thereby]. Xing BC, Yuan YH, Hu ZG, Liu YX, Han Y, Liu N, Chen WF, Wang Y. Zhonghua Yi Xue Za Zhi; 2004 Dec 02; 84(23):1980-2. PubMed ID: 15730810 [Abstract] [Full Text] [Related]
11. [Correlation of NY-ESO-1 gene and protein expression to metastasis and clinicopathologic features of hepatocellular carcinoma]. Zhang WM, Xiao G, Xie D, Zhang M, Guo AL, Wen JM. Ai Zheng; 2005 May 02; 24(5):622-6. PubMed ID: 15890110 [Abstract] [Full Text] [Related]
12. Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas. Mashino K, Sadanaga N, Tanaka F, Yamaguchi H, Nagashima H, Inoue H, Sugimachi K, Mori M. Br J Cancer; 2001 Sep 01; 85(5):713-20. PubMed ID: 11531257 [Abstract] [Full Text] [Related]
15. Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma. Ries J, Mollaoglu N, Vairaktaris E, Neukam FW, Nkenke E. Anticancer Res; 2009 Dec 01; 29(12):5125-30. PubMed ID: 20044626 [Abstract] [Full Text] [Related]
16. [Expression of NY-ESO-1 and LAGE-1 cancer-testis antigens in hepatocellular carcinoma]. Zhang WM, Xiao G, Zhang M, Guo AL, Dong Y, Wen JM. Zhonghua Bing Li Xue Za Zhi; 2005 Apr 01; 34(4):202-5. PubMed ID: 16091172 [Abstract] [Full Text] [Related]
18. Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer. Wang Y, Wu XJ, Zhao AL, Yuan YH, Chen YT, Jungbluth AA, Gnjatic S, Santiago D, Ritter G, Chen WF, Old LJ, Ji JF. Cancer Immun; 2004 Nov 01; 4():11. PubMed ID: 15516106 [Abstract] [Full Text] [Related]
19. Evaluation of LAGE-1 and NY-ESO-1 expression in multiple myeloma patients to explore possible benefits of their homology for immunotherapy. de Carvalho F, Vettore AL, Inaoka RJ, Karia B, Andrade VC, Gnjatic S, Jungbluth AA, Colleoni GW. Cancer Immun; 2011 Jan 20; 11():1. PubMed ID: 21247062 [Abstract] [Full Text] [Related]
20. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue. Hudolin T, Juretic A, Spagnoli GC, Pasini J, Bandic D, Heberer M, Kosicek M, Cacic M. Prostate; 2006 Jan 01; 66(1):13-8. PubMed ID: 16114059 [Abstract] [Full Text] [Related] Page: [Next] [New Search]